Business Standard
New drug may boost brain power in Alzheimer’s patients Click here to read article
New drug may boost brain power in Alzheimer’s patients Click here to read article
New Alzheimer’s drug shows 4 times more effective than current pill: Australian researchers Click here to read article
Victorians first to trial breakthrough brain booster pill Click here to read article
Melbourne researchers have found a new drug is up to four times more effective at treating Alzheimer’s disease than existing medication Click here to watch story
NEW YORK, NY, July 22, 2015 – Anavex Life Sciences Corp. (“Anavex” or the “Company”) (OTCQX: AVXL) today announced initial positive cognitive data for ANAVEX 2-73, the Company’s lead investigational oral treatment for Alzheimer’s targeting sigma-1 and muscarinic receptors, which is believed to reduce protein misfolding including reduction of beta amyloid, tau and inflammation. Cognitive…
Anavex Presents Early Evidence of Improving Cognition in Patients with Alzheimer’s Disease at AAIC 2015 Click here to read story
(OTCQX: AVXL) ANAVEX LIFE SCIENCES CORP. – CEO & Pres: Christopher Missling Click here to listen to interview